Drug
Leo 32731
Leo 32731: highest development phase Phase 2, developed by LEO Pharma. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| LEO 32731 NCT02888236 | Phase 2 | Psoriasis Vulgaris |
| LEO 32731 NCT03231124 | Phase 1 | Psoriasis Vulgaris |
Latest
No recent events.
Follow Leo 32731 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.